Tourmaline Bio Inc [TRML] stock prices are down -0.06% to $47.72 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TRML shares have gain 0.06% over the last week, with a monthly amount glided 103.02%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tourmaline Bio Inc [NASDAQ: TRML] stock has seen the most recent analyst activity on April 23, 2025, when Chardan Capital Markets initiated its Buy rating and assigned the stock a price target of $70. Previously, Wedbush started tracking the stock with Outperform rating on March 06, 2025, and set its price target to $42. On December 06, 2024, BMO Capital Markets initiated with a Outperform rating and assigned a price target of $50 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $49 on November 11, 2024. Jefferies initiated its recommendation with a Buy and recommended $41 as its price target on December 15, 2023. In a note dated November 17, 2023, Truist initiated a Buy rating and provided a target price of $43 on this stock.
The stock price of Tourmaline Bio Inc [TRML] has been fluctuating between $11.56 and $47.79 over the past year. Currently, Wall Street analysts expect the stock to reach $47.9 within the next 12 months. Tourmaline Bio Inc [NASDAQ: TRML] shares were valued at $47.72 at the most recent close of the market. An investor can expect a potential return of 0.38% based on the average TRML price forecast.
Analyzing the TRML fundamentals
Gross Profit Margin for this corporation currently stands at -0.05% with Operating Profit Margin at -2561.22%, Pretax Profit Margin comes in at -2211.85%, and Net Profit Margin reading is -2211.85%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -0.31 and Total Capital is -0.4. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 47.67 points at the first support level, and at 47.62 for the second support level. However, for the 1st resistance point, the stock is sitting at 47.77, and for the 2nd resistance point, it is at 47.82.
Ratios To Look Out For
It’s worth pointing out that Tourmaline Bio Inc [NASDAQ:TRML]’s Current Ratio is 24.68. As well, the Quick Ratio is 24.68, while the Cash Ratio is 3.11.
